ArticleGalen medical journal2025
Comparison of the Effects of Tamarind Seed Extract (Tamarindus Indica L.) with Sertraline in Treating Premature Ejaculation: A Randomized Double-blind Trial : Tamarind vs. Sertraline in PE Treatment.
Article in Galen medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Premature ejaculation (PE) is a prevalent male sexual disorder often untreated due to embarrassment. This study compares the efficacy of tamarind seed extract (Tamarindus indica L.) with sertraline in treating PE. Materials and Methods: In this randomized, double-blind, parallel-group trial, 41 men diagnosed with PE at urology and psychiatric clinics in Shiraz, Iran (2023) were enrolled. Participants were randomly assigned to receive either 80 mg tamarind seed extract capsules (Group A, n=20) or 50 mg sertraline tablets (Group B, n=21) daily for 4 weeks. The primary outcome was the Premature Ejaculation Diagnostic Tool (PEDT) score, with secondary outcomes including International Index of Erectile Function (IIEF) scores (erectile function, orgasmic function, sexual desire, intercourse satisfaction, overall satisfaction) and side effects. Data were analyzed using SPSS version 22 with t-tests and ANOVA (P0.05). Results: Both treatments significantly improved PEDT scores (P=0.001, η_p^2=0.76, 95% CI for mean difference: [-6.95, -4.95]) and IIEF subscales (P0.01). No significant differences were observed between groups (P=0.69, η_p^2=0.10) or in the time-group interaction (P=0.42, η_p^2=0.15). Side effects were minimal in both groups. Conclusion: The findings indicate a potential relationship between tamarind seed extract and improvements in premature ejaculation and related factors, comparable to sertraline; however, these results should be interpreted with caution and require further validation through additional research. Trial registration number: IRCT20140926019295N4.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.